144 related articles for article (PubMed ID: 28414759)
1. Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease.
Morimoto T; Mineharu Y; Ono K; Nakatochi M; Ichihara S; Kabata R; Takagi Y; Cao Y; Zhao L; Kobayashi H; Harada KH; Takenaka K; Funaki T; Yokota M; Matsubara T; Yamamoto K; Izawa H; Kimura T; Miyamoto S; Koizumi A
PLoS One; 2017; 12(4):e0175649. PubMed ID: 28414759
[TBL] [Abstract][Full Text] [Related]
2. RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis.
Wang Y; Mambiya M; Li Q; Yang L; Jia H; Han Y; Liu W
J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2259-2270. PubMed ID: 29752070
[TBL] [Abstract][Full Text] [Related]
3. RNF213 vasculopathy manifested in various forms within a family: A case report.
Lim SS; Park S; Oh BH; Jung K; Bae JW; Bae DH
Medicine (Baltimore); 2023 Dec; 102(50):e36627. PubMed ID: 38115307
[TBL] [Abstract][Full Text] [Related]
4. A Noonan-like pediatric patient with a de novo CBL pathogenic variant and an RNF213 polymorphism p.R4810K presenting with cardiopulmonary arrest due to left main coronary artery ostial atresia.
Chida-Nagai A; Tonoki H; Makita N; Ishiyama H; Ihara M; Maruo Y; Tsujioka T; Sasaki D; Izumi G; Yamazawa H; Kato N; Ito M; Fujimura M; Sasaki O; Takeda A
Am J Med Genet A; 2023 Dec; 191(12):2837-2842. PubMed ID: 37554039
[TBL] [Abstract][Full Text] [Related]
5. Synergistic Interaction of Thyroid Autoantibodies and Ring Finger Protein 213 Variant in Moyamoya Disease.
Thamamongood T; Hara S; Akagawa H; Inaji M; Tanaka Y; Nariai T; Maehara T
Neurol Med Chir (Tokyo); 2024 Jan; 64(1):43-49. PubMed ID: 38057092
[TBL] [Abstract][Full Text] [Related]
6. RNF213 Polymorphisms in Intracranial Artery Dissection.
Zedde M; Grisendi I; Assenza F; Napoli M; Moratti C; Pavone C; Bonacini L; Di Cecco G; D'Aniello S; Stoenoiu MS; Persu A; Valzania F; Pascarella R
Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927660
[TBL] [Abstract][Full Text] [Related]
7. RNF213-Related Vasculopathy: Various Systemic Vascular Diseases Involving RNF213 Gene Mutations: Review.
Murai Y; Matano F; Kubota A; Nounaka Y; Ishisaka E; Shirokane K; Koketsu K; Nakae R; Tamaki T
J Nippon Med Sch; 2024; 91(2):140-145. PubMed ID: 38777780
[TBL] [Abstract][Full Text] [Related]
8. Rare RNF213 variant in adolescent with moyamoya disease.
Cardoso I; Pinto M; Araújo A; Vila-Real M
Rev Neurol; 2023 Mar; 76(5):177-181. PubMed ID: 36843178
[TBL] [Abstract][Full Text] [Related]
9. Moyamoya disease in Southeast Asians: genetic and autopsy data, new cases, systematic review, and meta-analysis of all patients from the literature.
Strunk D; Bauer P; Keyvani K; Diehl RR; Veltkamp R; Berlit P; Meuth SG; Timmermann L; Schwitalla JC; Kraemer M
J Neurol; 2024 Jun; 271(6):3328-3339. PubMed ID: 38478032
[TBL] [Abstract][Full Text] [Related]
10. Detailed phenotype of
Zhou H; Jing J; Pu Y; Li W; Meng X; Wang A; Zuo Y; Xu Z; Xu Q; Suo Y; Li H; Wang Y
Stroke Vasc Neurol; 2023 Dec; 8(6):503-510. PubMed ID: 37137523
[TBL] [Abstract][Full Text] [Related]
11. Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism.
Ahel J; Lehner A; Vogel A; Schleiffer A; Meinhart A; Haselbach D; Clausen T
Elife; 2020 Jun; 9():. PubMed ID: 32573437
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the association between RNF213 polymorphisms and clinical features of moyamoya disease in Asian population.
Jiang X; Liu L; Ai S; Xie X; Deng J; Jiang Z; Teng B; Liu C; Huang H
Clin Neurol Neurosurg; 2023 Aug; 231():107801. PubMed ID: 37267801
[TBL] [Abstract][Full Text] [Related]
13. Aplastic or twig-like middle cerebral artery and cardiogenic cerebral embolism mimicking moyamoya disease with RNF213 polymorphism: A case report.
Inoue H; Oomura M; Nishikawa Y; Mase M; Matsukawa N
Interv Neuroradiol; 2022 Dec; 28(6):634-638. PubMed ID: 34913393
[TBL] [Abstract][Full Text] [Related]
14. RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway.
Ye F; Niu X; Liang F; Dai Y; Liang J; Li J; Wu X; Zheng H; Qi T; Sheng W
Brain; 2023 Nov; 146(11):4674-4689. PubMed ID: 37399508
[TBL] [Abstract][Full Text] [Related]
15. Association of thyroid peroxidase antibody with the RNF213 p.R4810K variant in ischemic stroke/transient ischemic attack.
Yoshimoto T; Ishiyama H; Hattori Y; Nishimura K; Okada Y; Watanabe H; Ohyagi Y; Akaiwa Y; Miyamoto T; Kawamoto M; Ichijo M; Inoue H; Matsukawa N; Mizuno T; Matsuyama H; Tomimoto H; Kawakami D; Toyoda K; Koga M; Ihara M
Atherosclerosis; 2023 Oct; 382():117281. PubMed ID: 37722316
[TBL] [Abstract][Full Text] [Related]
16. High-resolution MRI vessel wall enhancement in moyamoya disease: risk factors and clinical outcomes.
Hao F; Han C; Lu M; Wang Y; Gao G; Wang Q; Liu S; Liu S; Wang M; Ren B; Zou Z; Yu D; Sun C; Zhang Q; Guo Q; Liu W; Sun Z; Cai J; Duan L
Eur Radiol; 2024 Jan; ():. PubMed ID: 38172442
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide association study identifies novel susceptibilities to adult moyamoya disease.
Jeon JP; Hong EP; Ha EJ; Kim BJ; Youn DH; Lee S; Lee HC; Kim KM; Lee SH; Cho WS; Kang HS; Kim JE
J Hum Genet; 2023 Oct; 68(10):713-720. PubMed ID: 37365321
[TBL] [Abstract][Full Text] [Related]
18. Recurrent Cerebral Infarction Due to Moyamoya Disease Complicated With Systemic Lupus Erythematosus: A Case Report and Literature Review.
Wang Q; Yao Q; Yuan S; Shen Y; Feng Y; Liu L; Zhu Y; Zhao Y; Cui J; Qin J; Tian J; Zhao R; Liu L; Zhou Y; Liu X
Neurologist; 2024 Jan; 29(1):4-13. PubMed ID: 37582681
[TBL] [Abstract][Full Text] [Related]
19.
Shin HS; Park GH; Choi ES; Park SY; Kim DS; Chang J; Hong JM
J Cereb Blood Flow Metab; 2024 Apr; ():271678X241245557. PubMed ID: 38573771
[TBL] [Abstract][Full Text] [Related]
20. Posterior cerebral artery involvement in unilateral moyamoya disease is exclusively ipsilateral and influenced by RNF213 mutation gene dose: The SUPRA Japan study: PCA involvement in unilateral moyamoya.
Mineharu Y; Takagi Y; Koizumi A; Morimoto T; Funaki T; Hishikawa T; Araki Y; Hasegawa H; Takahashi JC; Kuroda S; Houkin K; Miyamoto S;
J Stroke Cerebrovasc Dis; 2024 Feb; 33(2):107513. PubMed ID: 38141320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
